Stefania Bartolini
Impact in
Papers in
- Genetics 65
- Glioma Diagnosis and Treatment 61
-
- Lung Cancer Treatments and Mutations 23
- Brain Metastases and Treatment 21
- Co-authors
- Federico Cappuzzo (26 shared papers)Lucio Crinò (22 shared papers)Enrico Franceschi (67 shared papers)Luca Toschi (10 shared papers)Giovanni Luca Ceresoli (9 shared papers)Alba A. Brandes (51 shared papers)Vanesa Gregorc (9 shared papers)Alicia Tosoni (51 shared papers)
- Journals
- Journal of Clinical Oncology (18 papers)Cancers (6 papers)British Journal of Cancer (6 papers)Frontiers in Oncology (6 papers)Future Oncology (5 papers)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Stefania Bartolini
97 papers receiving 3.7k citations
Stefania Bartolini's Hit Papers
Peers
Comparison fields: 5 of 108
- Genetics 1.4k
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 2.0k
- Cancer Research 644
- Radiology, Nuclear Medicine and Imaging 560
Countries citing papers authored by Stefania Bartolini
This map shows the geographic impact of Stefania Bartolini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefania Bartolini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefania Bartolini more than expected).
Fields of papers citing papers by Stefania Bartolini
This network shows the impact of papers produced by Stefania Bartolini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefania Bartolini. The network helps show where Stefania Bartolini may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefania Bartolini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 104 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients Hit paper breakdown → | 2008 | 634 |
| 2 | 2004 | 311 | |
| 3 | 2005 | 300 | |
| 4 | 2005 | 296 | |
| 5 | 2004 | 277 | |
| 6 | 2003 | 175 | |
| 7 | 2007 | 174 | |
| 8 | 2010 | 99 | |
| 9 | 2003 | 92 | |
| 10 | 2006 | 84 | |
| 11 | 2007 | 72 | |
| 12 | 2007 | 71 | |
| 13 | 2013 | 68 | |
| 14 | 2005 | 62 | |
| 15 | 2017 | 60 | |
| 16 | 2004 | 56 | |
| 17 | The effect of re-operation on survival in patients with recurrent glioblastoma. | 2015 | 55 |
| 18 | 2006 | 45 | |
| 19 | 2006 | 44 | |
| 20 | 2004 | 41 |
About Stefania Bartolini
Stefania Bartolini is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Cancer Research, having authored 104 papers that have together received 3.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (61 papers), Lung Cancer Treatments and Mutations (23 papers), Brain Metastases and Treatment (21 papers), Radiomics and Machine Learning in Medical Imaging (17 papers), Meningioma and schwannoma management (13 papers), HER2/EGFR in Cancer Research (11 papers), Colorectal Cancer Treatments and Studies (10 papers) and Cancer, Hypoxia, and Metabolism (9 papers). The work is most often cited by research in Genetics (1.4k citations), Oncology (1.8k citations), Pulmonary and Respiratory Medicine (2.0k citations), Cancer Research (644 citations) and Radiology, Nuclear Medicine and Imaging (560 citations). Stefania Bartolini has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Federico Cappuzzo, Lucio Crinò, Enrico Franceschi, Luca Toschi, Giovanni Luca Ceresoli, Alba A. Brandes, Vanesa Gregorc, Alicia Tosoni, Giovanna Finocchiaro and Elisa Rossi. Their work appears in journals such as Journal of Clinical Oncology, Cancers, British Journal of Cancer, Frontiers in Oncology and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.